Increased maternal and cord blood betatrophin in gestational diabetes

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Wawrusiewicz Kurylonek, Natalia ^a   Telejko, Beata ^a   Kuzmicki, Mariusz ^a   Sobota, Angelika ^a   Lipinska, Danuta ^a   Pliszka, Justyna ^a   Raczkowska, Beata ^a   Kuc, Pawel ^a   Urban, Remigiusz ^a   Szamatowicz, Jacek ^a   Kretowski, Adam ^a   Laudanski, Piotr ^a   Gorska, Maria ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BETATROPHIN; IRISIN; MESSENGER RNA; PEPTIDE; UNCLASSIFIED DRUG; FIBRONECTIN; FNDC5 PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; INSULIN; LIPASIN PROTEIN, HUMAN; PEPTIDE HORMONE;

ADULT; ARTICLE; C19ORF80 GENE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FNDC5 GENE; GENE; GENE EXPRESSION; GESTATIONAL AGE; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PLACENTA; PREGNANCY DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SUBCUTANEOUS FAT; UMBILICAL CORD BLOOD; BLOOD; CASE CONTROL STUDY; FETUS BLOOD; GLUCOSE BLOOD LEVEL; METABOLISM; NEWBORN; PREGNANCY; UPREGULATION;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; FETAL BLOOD; FIBRONECTINS; HUMANS; INFANT, NEWBORN; INSULIN; PEPTIDE HORMONES; PREGNANCY; UP-REGULATION;

EID: 84938366438     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131171     Document Type: Article

References (35)

1. Fu Z, Yao F, Abou-Samra AB, Zhang R. Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family. Biochem Biophys Res Commun 2013; 430: 1126-31. doi: 10.1016/j.bbrc.2012.12.025 PMID: 23261442
2. Zhang R. Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 2012; 424: 786-792. doi: 10.1016/j.bbrc.2012.07.038 PMID: 22809513
3. Quagliarini F, Wang Y, Kozlitina J, Grishin NV, Hyde R, Boerwinkle E, et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A 2012; 109: 19751-19756. doi: 10.1073/pnas.1217552109 PMID: 23150577
4. Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab 2012; 303: E334-E351. doi: 10.1152/ajpendo.00084.2012 PMID: 22569073
5. Yi P1, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell 2013; 153: 747-758. doi: 10.1016/j.cell.2013.04.008 PMID: 23623304
6. Gusarova V, Alexa CA, Na E, Stevis PE, Xin Y, Bonner-Weir S, et al. ANGPTL8/betatrophin does not control pancreatic beta cell expansion. Cell 2014; 159:691-696. doi: 10.1016/j.cell.2014.09.027 PMID: 25417115
7. Jiao Y, Le Lay J, Yu M, Naji A, Kaestner KH. Elevated mouse hepatic betatrophin expression does not increase human β-cell replication in the transplant setting. Diabetes 2014; 63: 1283-1288. doi: 10.2337/db13-1435 PMID: 24353178
8. Wang Y, Quagliarini F, Gusarova V, Gromada J, Valenzuela DM, Cohen JC, et al. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc Natl Acad Sci U S A 2013; 110: 16109-16114. doi: 10.1073/pnas.1315292110 PMID: 24043787
9. Fu Z, Berhane F, Fite A, Seyoum B, Abou-Samra AB, Zhang R. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity. Sci Rep 2014; 23:5013. doi: 10.1038/srep05013
10. Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 2014; 63: 514-25. doi: 10.2337/db13-1106 PMID: 24150604
11. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481: 463-8. doi: 10.1038/nature10777 PMID: 22237023
12. Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L, et al. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol. 2014; 592: 1091-1107. doi: 10.1113/jphysiol.2013.264655 PMID: 24297848
13. Espes D, Martinell M, Carlsson PO. Increased circulating betatrophin concentrations in patients with type 2 diabetes. Int J Endocrinol 2014; 2014:323407. doi: 10.1155/2014/323407 PMID: 24963292
14. Hu H, Sun W, Yu S, Hong X, Qian W, Tang B, et al. Increased circulating levels of betatrophin in newly diagnosed type 2 diabetic patients. Diabetes Care 2014; 37: 2718-2722. doi: 10.2337/dc14-0602 PMID: 25024395
15. Chen X, Lu P, He W, Zhang J, Liu L, Yang Y, et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab 2015; 100:E96-100. doi: 10.1210/jc.2014-2300 PMID: 25303484
16. Ebert T, Kralisch S, Hoffmann A, Bachmann A, Lössner U, Kratzsch J, et al. Circulating Angiopoietin-like Protein 8 Is Independently Associated With Fasting Plasma Glucose and Type 2 Diabetes Mellitus. J Clin Endocrinol Metab 2014; 99:E2510-E2517. doi: 10.1210/jc.2013-4349 PMID: 25325797
17. Espes D1, Lau J, Carlsson PO. Increased levels of irisin in people with long-standing Type 1 diabetes. Diabet Med. 2015 Feb 25. doi: 10.1111/dme.12731 [Epub ahead of print]
18. Yamada H, Saito T, Aoki A, Asano T, Yoshida M, Ikoma A, et al. Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes. Endocr J. 2015 Mar 5. [Epub ahead of print]
19. Fenzl A, Itariu BK, Kosi L, Fritzer-Szekeres M, Kautzky-Willer A, Stulnig TM, et al. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals. Diabetologia 2014; 57: 1204-1208. doi: 10.1007/s00125-014-3208-x PMID: 24623100
20. Gómez-Ambrosi J, Pascual E, Catalán V, Rodríguez A, Ramírez B, Silva C, et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab. 2014; 99: E2004-E2009. doi: 10.1210/jc.2014-1568 PMID: 25050901
21. Buchanan TA, Xiang A, Kjos SL, Watanabe R. What is gestational diabetes? Diabetes Care 2007; 30 (Supplement 2): S105-111.
22. Telejko B, Kuzmicki M, Wawrusiewicz-Kurylonek N, Szamatowicz J, Nikolajuk A, Zonenberg A, et al. Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus. Diabetes Res Clin Pract 2010; 87:176-83. doi: 10.1016/j.diabres.2009.10.018 PMID: 19926159
23. Telejko B, Kuzmicki M, Zonenberg A, Modzelewska A, Niedziolko-Bagniuk K, Ponurkiewicz A, et al. Ghrelin in gestational diabetes: serum level and mRNA expression in fat and placental tissue. Exp Clin Endocrinol Diabetes 2010; 118:87-92. doi: 10.1055/s-0029-1238313 PMID: 20180161
24. Kuzmicki M, Telejko B, Wawrusiewicz-Kurylonek N, Citko A, Lipinska D, Pliszka J, et al. The expression of suppressor of cytokine signaling 1 and 3 in fat and placental tissue from women with gestational diabetes. Gynecol Endocrinol 2012; 28:841-844. doi: 10.3109/09513590.2012.683055 PMID: 22587677
25. Kuzmicki M, Telejko B, Wawrusiewicz-Kurylonek N, Lipinska D, Pliszka J, Wilk J, et al. The expression of genes involved in NF-κB activation in peripheral blood mononuclear cells of patients with gestational diabetes. Eur J Endocrinol 2013; 168:419-427. doi: 10.1530/EJE-12-0654 PMID: 23230212
26. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. WHO Guidelines Approved by the Guidelines Review Committee Geneva: World Health Organization; 2013.
27. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22:1462-1470. PMID: 10480510
28. Retnakaran R, Qi Y, Goran MI, Hamilton JK. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 2009; 26:1198-1203. doi: 10.1111/j.1464-5491.2009.02841.x PMID: 20002470
29. Plaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Research 2002; 30: e36. PMID: 11972351
30. Tokumoto S, Hamamoto Y, Fujimoto K, Yamaguchi E, Okamura E, Honjo S, et al. Correlation of circulating betatrophin concentrations with insulin secretion capacity, evaluated by glucagon stimulation tests. Diabet Med. 2015 Jan 19. doi: 10.1111/dme.12696 [Epub ahead of print]
31. Kuzmicki M, Telejko B, Lipinska D, Pliszka J, Szamatowicz M, Wilk J, et al. Serum irisin concentration in women with gestational diabetes. Gynecol Endocrinol 2014; 30: 636-639. doi: 10.3109/09513590.2014.920006 PMID: 24850254
32. Ebert T, Stepan H, Schrey S, Kralisch S, Hindricks J, Hopf L, et al. Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine 2014; 65: 153-158. doi: 10.1016/j.cyto.2013.11.009 PMID: 24355429
33. Yuksel MA, Oncul M, Tuten A, Imamoglu M, Acikgoz AS, Kucur M, et al. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus. Diabetes Res Clin Pract 2014; 104: 171-175. doi: 10.1016/j.diabres.2013.12.025 PMID: 24447809
34. Piya MK, Harte AL, Sivakumar K, Tripathi G, Voyias PD, James S, et al. The identification of irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers, and gestational diabetes. Am J Physiol Endocrinol Metab 2014; 306: E512-E518. doi: 10.1152/ajpendo.00308.2013 PMID: 24398403
35. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012; 61: 1725-1738. doi: 10.1016/j.metabol.2012.09.002 PMID: 23018146